2 results
Approved WMORecruitment stopped
To assess whether a combination of ciprofloxacin and adalimumab is more effective than adalimumab alone.
Approved WMORecruitment stopped
To demonstrate non-inferiority of oral fosfomycin-trometamol compared to oral ciprofloxacin as a step-down treatment for E.coli AF-UTI in women for the cumulative incidence of survival and clinical cure (resolution of symptoms) 6-10 days post-…